‌

US Patent 9765060 Phosphatidylinositol 3-kinase inhibitors

Patent 9765060 was granted and assigned to Gilead Sciences on September, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9765060

Patent Inventor Names

Gary Phillips0

Leena Patel0

Musong Kim0

Stephane Perreault0

Devan Naduthambi0

Jennifer A. Treiberg0

Jerry Evarts0

Joshua Kaplan0

...

Date of Patent

September 19, 2017

Patent Application Number

14747931

Date Filed

June 23, 2015

Patent Citations Received

‌

US Patent 12122833 Combination therapies of HDAC inhibitors and PD-1 inhibitors

Patent Primary Examiner

‌

Rebecca Anderson

Patent abstract

The present disclosure provides phosphatidylinositol 3-kinase (PI3K) inhibitors of formula (J),

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9765060 Phosphatidylinositol 3-kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API